Clinical Trials Sponsored by The Prompt Institute

Total 5037 results

Karolinska Institutet
The Swedish Research Council

Completed

A web-and Mobile Phone-based Intervention in 4-year-olds: a Population-based Randomized Controlled Trial

Obesity

Sweden
Karolinska Institutet
The Swedish Research Council

Completed

PANS - A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort

PANDAS | Obsessive-compulsive Disorder | Obsessive-compulsive Disorder With Acute Onset | Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections | Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) | Childhood Acute Neuropsychiatric Symptoms (CANS)

Sweden
Karolinska Institutet
The Swedish Research Council

Completed

Small Step Intervention for Infants With Cerebral Palsy and Other Neurodevelopmental Disorders (smallstep)

Cerebral Palsy | Gross Motor Development Delay

Sweden
Institut Guttmann
The University of Queensland

Unknown

Multisensory Stimulation and Enriched Environments During Post-traumatic Amnesia

Brain Injuries, Traumatic | Alteration of Cognitive Function | Confusional State | Sensory Motor System Disorder

Spain
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); The Ottawa Hospital; The Physicians... and other collaborators

Terminated

Accelerated Titration of Oxytocin for Nulliparous Patients With Labour Dystocia: ACTION Pilot Study (ACTION)

Labour Dystocia

Canada
The National Institute of Lymphology
The DrMarga Practice Group; The Center for Restorative Breast Surgery, LLC

Unknown

Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment

Breast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | Congenital Lymphedema | Acquired Lymphedema

United States
The Netherlands Cancer Institute
Hoffmann-La Roche

Not yet recruiting

NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial (TONIC-3)

Metastatic Breast Cancer
Hellenic Institute for the Study of Sepsis

Recruiting

Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT) (REACT)

Community-acquired Pneumonia

Greece
The Netherlands Cancer Institute
Daiichi Sankyo, Inc.

Not yet recruiting

Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT

EGFR Gene Mutation | Non-Small Cell Lung Carcinoma | Advanced Non-Small Cell Squamous Lung Cancer
Brigham and Women's Hospital
The Fenway Institute

Recruiting

Next Generation Ingestible Sensors for Medication Adherence Measurement (NextGen)

HIV Infection | Adherence, Medication | Antiretroviral Therapy | Adherence, Treatment | Pre-Exposure Prophylaxis

United States
Ottawa Hospital Research Institute
The Ottawa Hospital

Not yet recruiting

Indwelling vs Intermittent Catheterization Pilot Study (PEE)

Urinary Tract Infections | Hip Fractures | Catheter Complications | Urogenital

Canada
The Aurum Institute NPC
Johns Hopkins University

Recruiting

Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients (1 to 3)

Tuberculosis | HIV Seropositivity | Household Contact

South Africa, India, Indonesia, Mozambique
The Royal's Institute of Mental Health Research

Recruiting

Effects of Aerobic Exercise Intensity on Clinical & Neural Outcomes in Depressed Youth

Depression

Canada
The Netherlands Cancer Institute
Hoffmann-La Roche

Recruiting

Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN) (TARZAN)

Rectal Cancer

Netherlands
The Netherlands Cancer Institute
Dutch Cancer Society

Recruiting

"Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal Cancer

Rectal Neoplasms

Netherlands, Belgium
Hellenic Institute for the Study of Sepsis

Active, not recruiting

Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia (INSPIRE)

Hospital-acquired Pneumonia | Community-acquired Pneumonia

Greece
The Rogosin Institute
Janssen Research & Development, LLC

Completed

Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease

Proteinuria | Chronic Kidney Disease | Kidney Injury

United States
Hellenic Institute for the Study of Sepsis

Completed

Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia (ACCESS)

Sepsis | Mortality | Inflammatory Response | Biomarkers | SIRS | Community-acquired Pneumonia

Greece
The Netherlands Cancer Institute
Bristol-Myers Squibb

Active, not recruiting

Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab (OpACIN-neo)

Malignant Melanoma Stage III

Austria, Netherlands, Australia, Sweden
The Netherlands Cancer Institute
Hoffmann-La Roche

Completed

PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study (PERICLES)

Penile Cancer

Netherlands
Atos Medical AB
The Netherlands Cancer Institute

Completed

Clinical Feasibility of a New Voice Prosthesis

Laryngectomy

Netherlands
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

Malignant Mesothelioma

United States
Atos Medical AB
The Netherlands Cancer Institute

Completed

Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis

Total Laryngectomy

Netherlands
Hellenic Institute for the Study of Sepsis

Completed

suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) (SAVE)

Virus Diseases | COVID-19 | Corona Virus Infection | Lower Respiratory Tract Infection Viral

Greece
The Netherlands Cancer Institute
Bristol-Myers Squibb

Active, not recruiting

Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients (OpACIN)

Stage III Skin Melanoma

Netherlands
The Netherlands Cancer Institute
Roche Pharma AG

Completed

Carboplatin-cyclophosphamide Combined With Atezolizumab (PROLOG)

Breast Cancer | Ovarian Cancer | Cervix Cancer | Endometrial Cancer

Netherlands
Hellenic Institute for the Study of Sepsis

Completed

Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early (ACHIEVE)

Virus Diseases | COVID-19 | Corona Virus Infection

Greece
Hellenic Institute for the Study of Sepsis

Unknown

suPAR to Guide Antibiotics in Emergency Department

Sepsis

Greece
Hellenic Institute for the Study of Sepsis

Completed

Pulse Photoplethysmography as an Early Tool for the Diagnosis of Sepsis (PROUD-1)

Sepsis

Greece
Hellenic Institute for the Study of Sepsis

Completed

A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis (PROVIDE)

Sepsis | Macrophage Activation Syndrome

Greece
Hellenic Institute for the Study of Sepsis

Completed

A Clinical Trial of Procalcitonin-guided Antimicrobial Therapy in Sepsis (PROGRESS)

Sepsis

Greece
S.M.Chang, MD
The Methodist Hospital Research Institute

Completed

Reducing Radioisotope Dose: the Half-Dose CZT Study

Coronary Artery Disease

United States
The Netherlands Cancer Institute
Dutch Cancer Society

Completed

Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms

Breast Cancer Survivors | Climacteric Symptoms

Netherlands
Mayo Clinic
The Gertner Institute; ReAbility Online

Completed

Evaluation of a Tele-Rehabilitation Service Program

Stroke | Paresis

United States
The Cleveland Clinic
National Eye Institute (NEI)

Completed

PIONEER: Intraoperative and Perioperative OCT Study (PIONEER)

Retinal Detachment | Epiretinal Membrane | Fuchs Endothelial Dystrophy | Macular Hole

United States
The Netherlands Cancer Institute
Astellas Pharma Inc

Completed

Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation (DARANA)

Prostate Cancer | Androgen Receptor Abnormal | DNA
The Netherlands Cancer Institute
Bristol-Myers Squibb

Completed

Nivolumab in Patients With Recurrent Malignant Mesothelioma (NivoMes)

Malignant Pleural Mesothelioma
The Advanced Gynecologic Surgery Institute
Medtronic - MITG

Withdrawn

a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy. (VLocmyo)

Infertility | Uterine Fibroids

United States
The George Institute for Global Health, China

Completed

Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3,CPACS-3 (CPACS-3)

Acute Coronary Syndromes

China
The Methodist Hospital Research Institute
Schering-Plough

Terminated

Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC

Carcinoma, Renal Cell

United States
The Methodist Hospital Research Institute
Oxford BioMedica

Completed

Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer

Prostatic Neoplasms

United States
Rothman Institute Orthopaedics
The Anderson Orthopaedic Clinic

Completed

A Prospective, Randomized Trial Comparing Same Day Discharge and Overnight Hospital Stay Among Total Hip Arthroplasties Done by the Direct Anterior Approach

Osteoarthritis of the Hip

United States
The George Institute for Global Health, Australia

Completed

The Fluid Translation of Research Into Practice Study (Fluid-TRIPS)

Critical Care, Fluid Resuscitation

Australia
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Biological Therapy in Treating Patients With Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
The Cleveland Clinic

Completed

Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
The Cleveland Clinic

Withdrawn

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell Neoplasm

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia

Leukemia

United States
Atos Medical AB
The Netherlands Cancer Institute

Completed

Long Term Use of the Provox Vega 22.5

Total Laryngectomy

Netherlands
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer

Lung Cancer

United States
Atos Medical AB
The Netherlands Cancer Institute

Completed

Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy (N08HME)

Total Laryngectomy

Netherlands

Clinical Trials Sponsored by The Prompt Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations